Van Lanschot Kempen Investment Management’s Quest Diagnostics DGX Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.2M	Buy	256,298 +81,152	+46%	+$15.8M	0.44%	36
2025 Q4	$30.4M	Sell	175,146 -166,507	-49%	-$30.3M	0.26%	62
2025 Q3	$65.1M	Sell	341,653 -66,547	-16%	-$11.8M	0.58%	29
2025 Q2	$73.3M	Sell	408,200 -23,100	-5%	-$4.01M	0.7%	29
2025 Q1	$73M	Sell	431,300 -83,258	-16%	-$13.7M	0.76%	28
2024 Q4	$77.6M	Buy	514,558 +121,533	+31%	+$18.9M	0.77%	33
2024 Q3	$61M	Buy	393,025 +36,635	+10%	+$5.47M	0.62%	44
2024 Q2	$48.8M	Buy	+356,390	New	+$48.8M	0.55%	52

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Van Lanschot Kempen Investment Management's DGX Position: Q1 2026 in Review

Van Lanschot Kempen Investment Management increased its Quest Diagnostics (DGX) stake by 46% in Q1 2026, buying an estimated $15.8M and bringing the position to 256,298 shares worth $50.2M. The position accounts for 0.44% of the portfolio, ranked #36.

Van Lanschot Kempen Investment Management first reported a position in DGX in Q2 2024 and has held it in 8 quarters since. The position peaked at $77.6M in Q4 2024. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Van Lanschot Kempen Investment Management held 256,298 shares of Quest Diagnostics worth $50.2M as of Q1 2026.
Van Lanschot Kempen Investment Management bought 81,152 Quest Diagnostics shares in Q1 2026, an estimated $15.8M.
Quest Diagnostics made up 0.44% of Van Lanschot Kempen Investment Management's portfolio in Q1 2026, its #36 holding.
Van Lanschot Kempen Investment Management first reported a position in Quest Diagnostics in Q2 2024 and has held it in 8 quarters since.
Van Lanschot Kempen Investment Management's Quest Diagnostics position peaked at $77.6M in Q4 2024.
1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.